Evaluation of Gynecologic Cancer with MR Imaging, 18F-FDG PET/CT, and PET/MR Imaging
العنوان: | Evaluation of Gynecologic Cancer with MR Imaging, 18F-FDG PET/CT, and PET/MR Imaging |
---|---|
المؤلفون: | Farrokh Dehdashti, Onofrio A. Catalano, Susanna I. Lee |
المصدر: | Journal of Nuclear Medicine. 56:436-443 |
بيانات النشر: | Society of Nuclear Medicine, 2015. |
سنة النشر: | 2015 |
مصطلحات موضوعية: | Thiosemicarbazones, medicine.medical_specialty, Cu-labeled diacetyl-bis (N4-methylthiosemicarbazone) PET, medicine.medical_treatment, Uterine Cervical Neoplasms, Salvage therapy, Multimodal Imaging, Imaging modalities, dynamic contrast enhanced MRI, Coordination Complexes, Fluorodeoxyglucose F18, Gynecologic cancer, diffusion weighted imaging, Organometallic Compounds, medicine, Humans, Radiology, Nuclear Medicine and imaging, Tomography, Ovarian Neoplasms, Salvage Therapy, Modalities, Estradiol, business.industry, 16α-18F-fluoro-17β-estradiol PET, Prognosis, Magnetic Resonance Imaging, Mr imaging, X-Ray Computed, Radiation therapy, Neoplasm Recurrence, Local, Positron-Emission Tomography, Uterine Neoplasms, perfusion MRI, Female, Neoplasm Recurrence, Local, Tomography, X-Ray Computed, Fdg pet ct, Pet mr imaging, Radiology, business |
الوصف: | MR imaging and (18)F-FDG PET/CT play central and complementary roles in the care of patients with gynecologic cancer. Because treatment often requires combinations of surgery, radiotherapy, and chemotherapy, imaging is central to triage and to determining prognosis. This article reviews the use of the 2 imaging modalities in the initial evaluation of 3 common cancers: uterine cervical, uterine endometrial, and epithelial ovarian. Imaging features that affect management are highlighted, as well as the relative strengths and weaknesses of the 2 modalities. Use of imaging after initial therapy to assess for recurrence and to plan salvage therapy is described. Newer functional and molecular techniques in MR imaging and PET are evaluated. Finally, we describe our initial experience with PET/MR imaging, an emerging technology that may prove to be a mainstay in personalized gynecologic cancer care. |
تدمد: | 2159-662X 0161-5505 |
الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::529d563162f5ad708053d25ea4bbc1d1Test https://doi.org/10.2967/jnumed.114.145011Test |
حقوق: | OPEN |
رقم الانضمام: | edsair.doi.dedup.....529d563162f5ad708053d25ea4bbc1d1 |
قاعدة البيانات: | OpenAIRE |
تدمد: | 2159662X 01615505 |
---|